Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antiasthma Drugs: β2-Adrenoceptor Agonists01:25

Antiasthma Drugs: β2-Adrenoceptor Agonists

354
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
354
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

287
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
287
Hyperpnea and Hyperventilation01:25

Hyperpnea and Hyperventilation

1.3K
Hyperventilation refers to a higher-than-normal rate and depth of breathing, often associated with anxiety attacks. This excessive breathing surpasses the body's need to expel CO2, leading to a condition known as hypocapnia - an unusually low level of carbon dioxide in the blood. Hypocapnia can constrict cerebral blood vessels, reducing blood flow to the brain, which may result in dizziness or fainting. Early signs include tingling and muscle spasms in the hands and face, caused by falling...
1.3K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

551
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
551
Antiasthma Drugs: Methylxanthines01:24

Antiasthma Drugs: Methylxanthines

368
Theophylline, a member of the methylxanthine class of bronchodilators, has long been used in asthma management. While its exact mechanism of action is not fully understood, it is believed to have multiple effects on various cellular processes.
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
368
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids01:25

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

379
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
379

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Spectrum and epidemiology of neurological disorders and neuromuscular anomalies in pediatric population of Sialkot, Pakistan.

Pakistan journal of medical sciences·2026
Same author

The Successful Use of Noninvasive Ventilation in Severe Asthma Exacerbation: A Case Report and Review of the Literature.

Cureus·2026
Same author

Timing of insertable cardiac monitor implantation after embolic stroke of undetermined source and its impact on atrial fibrillation detection: A target trial emulation analysis.

International journal of stroke : official journal of the International Stroke Society·2026
Same author

Atrial fibrillation detection after embolic stroke of undetermined source: Development and validation of the CATCH-AF score.

International journal of stroke : official journal of the International Stroke Society·2026
Same author

Comparison of Drip-and-Ship Versus Mothership Delivery Models of Mechanical Thrombectomy Delivery.

Stroke (Hoboken, N.J.)·2026
Same author

Early versus delayed insertable cardiac monitor implantation after ESUS stroke and the yield of atrial fibrillation detection: A systematic review and meta-analysis.

International journal of stroke : official journal of the International Stroke Society·2025

Related Experiment Video

Updated: Sep 3, 2025

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
14:39

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

32.0K

Hypocalcemia Induced Bronchospasm.

Aneeta Kumari1, Kunal Nangrani2, Tsering Dolkar3

  • 1Pulmonary Medicine and Critical Care Medicine, One Brooklyn Health System, Interfaith Medical Center, Brooklyn, USA.

Cureus
|July 29, 2022
PubMed
Summary

Hypocalcemia can cause severe bronchospasm, even in individuals without a history of lung disease. Promptly identifying and treating low calcium levels can effectively resolve these respiratory symptoms.

Keywords:
bronchospasmhypocalcemiahypocalcemia induced bronchospasmmanagement of hypocalcemia induced bronchospasmpersistent bronchospasm

More Related Videos

In vitro Measurements of Tracheal Constriction Using Mice
10:20

In vitro Measurements of Tracheal Constriction Using Mice

Published on: June 25, 2012

20.9K
A Traditional Chinese Medicine Characteristic Therapy for Bronchial Asthma: Moxibustion
05:56

A Traditional Chinese Medicine Characteristic Therapy for Bronchial Asthma: Moxibustion

Published on: May 12, 2023

3.8K

Related Experiment Videos

Last Updated: Sep 3, 2025

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
14:39

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

32.0K
In vitro Measurements of Tracheal Constriction Using Mice
10:20

In vitro Measurements of Tracheal Constriction Using Mice

Published on: June 25, 2012

20.9K
A Traditional Chinese Medicine Characteristic Therapy for Bronchial Asthma: Moxibustion
05:56

A Traditional Chinese Medicine Characteristic Therapy for Bronchial Asthma: Moxibustion

Published on: May 12, 2023

3.8K

Area of Science:

  • Pulmonology
  • Endocrinology
  • Critical Care Medicine

Background:

  • Bronchospasm, characterized by acute airway narrowing, typically occurs in obstructive lung diseases.
  • Hypocalcemia, or low calcium levels, is an uncommon cause of bronchospasm.

Observation:

  • A 57-year-old male with no prior history of asthma or COPD presented with severe, intractable bronchospasm.
  • Initial investigations for common causes of respiratory distress were inconclusive.

Findings:

  • The patient was found to have profound hypocalcemia.
  • Treatment for hypocalcemia led to the complete resolution of bronchospasm and associated symptoms.

Implications:

  • This case highlights hypocalcemia as a rare but significant cause of bronchospasm.
  • Early recognition and management of hypocalcemia are crucial for effective treatment of unexplained bronchospasm.